跳至主要内容
临床试验/NCT02286466
NCT02286466已完成不适用

Mobile Application of Cognitive-Behavioral Therapy (CBT) for Anxiety and Cancer

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 145 人开始时间: 2015年2月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
145
试验地点
2
主要终点
Change in Anxiety Symptoms From Baseline to Post-assessment

研究概览

简要总结

The proposed study seeks to implement a randomized controlled trial to evaluate the effectiveness and generalizability of an efficacious cognitive-behavioral therapy (CBT) intervention for use as a self-administered mobile application (mobile app) to treat anxiety in patients with metastatic cancer.

详细描述

Background: Patients with advanced cancer often experience marked anxiety symptoms that are associated with poor quality of life, high physical symptom burden, and complications with medical treatment. We have demonstrated in prior NCI-funded research that individual cognitive-behavioral therapy (CBT), delivered in-person at a tertiary cancer center, is efficacious for treating heightened anxiety in this population. In our randomized-controlled trial of 40 patients with incurable solid tumors, we observed significant reductions in anxiety symptoms per self-report and blind clinician evaluation, with a large effect size underscoring the clinical benefit of the CBT intervention (Cohen's d=0.80). However, timely access to CBT, especially for patients in community clinic settings, is severely limited by shortened life expectancy, scheduling challenges associated with poor functional status, and the lack of trained clinicians and onsite mental health services.

Objective/Hypothesis: The goals of this study are to assess the feasibility and efficacy of delivering CBT for anxiety via mobile application (app) tailored to patients with advanced cancer. We will administer the intervention at two cancer centers, hypothesizing that patients with advanced cancer who receive CBT via mobile app will report significantly greater reductions in anxiety compared to those assigned to a time-matched control group using an online health educational program.

Specific Aims: The primary aims for the proposed project are 1) to adapt our successful CBT intervention for use as a self-administered, mobile application to treat anxiety in patients with advanced cancer; and, 2) to demonstrate the feasibility, efficacy, and generalizability of the CBT mobile app intervention for anxiety compared to an online health education program across two cancer centers (one academic and one community).

Study Design: We will employ sequential mixed qualitative and quantitative methods for intervention adaptation and testing. Specifically, we will dedicate year one of the award to creating and scripting the CBT mobile app intervention for anxiety, which will include multiple electronic features that enhance specificity to patients' individual cancer-related concerns. Up to six patients with metastatic cancer will participate in an initial open pilot study to explore the usability and acceptability of the prototype application. Data from qualitative interviews with these participants will be used to refine and adapt the intervention further. In year two, we will enroll and randomly assign patients with anxiety and metastatic cancer to receive either the CBT mobile app intervention or an online health education program. Patients will self-administer the intervention protocol using a tablet. The target enrollment for the randomized-controlled trial is 120 patients (CBT Mobile App N=60; Control N=60). Randomization will be stratified by study site and disease severity to demonstrate the generalizability of the intervention among patients with diverse malignancies in both academic and community cancer care settings.

Cancer Relevance: According to the American College of Surgeons Commission on Cancer Report (2011), an essential criterion for accreditation as a cancer center is timely patient access to screening and referral for treatment of psychological distress. Yet, most academic and community cancer clinics lack appropriate resources, staff, and training in evidence-based mental health therapies. The proposed project has the potential to address this critical unmet need by adapting an efficacious and clinically-meaningful CBT intervention to a patient-centered and user-friendly platform that can be accessed at home and while patients receive routine oncology care. If successful, our approach could be widely disseminated in a cost-effective manner across multiple oncology settings, greatly improving access to mental health services, especially for patients with cancer in resource-poor communities.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of a metastatic solid tumor
  • Report clinically significant anxiety symptoms (i.e., Hospital Anxiety and Depression Scale (HADS) -Anxiety Subscale > or equal to 8)
  • Anxiety is principal psychiatric problem
  • At least four weeks after cancer diagnosis
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • Age greater than 18 years
  • Ability to read and respond to questions in English

排除标准

  • Co-morbid delirium, dementia, or active and untreated major psychiatric condition such as schizophrenia will be excluded from the study

研究组 & 干预措施

Health Education Program

Active Comparator

The presence and usage of Health Education Program.

干预措施: Health Education Program (Behavioral)

CBT Mobile Application

Experimental

The presence and usage of a CBT Mobile Application.

干预措施: CBT Mobile Application (Behavioral)

结局指标

主要结局

Change in Anxiety Symptoms From Baseline to Post-assessment

时间窗: 1) Baseline (within 2 weeks after enrollment), 2) Post-Assessment (8-12 weeks after baseline)

Hamilton Anxiety Rating Scale (HAM-A): The HAM-A is a clinician-administered interview used widely in psychiatry research to evaluate anxiety symptoms. Consisting of 14 items that are scored on a scale from 0 (not present) to 4 (very severe), the HAM-A total score ranges from 0 to 56, with higher scores indicating worse anxiety symptoms.

次要结局

  • Change in Mood Symptoms From Baseline to Post-assessment(1) Baseline (within 2 weeks after enrollment), 2) and Post-Assessment (8-12 weeks after baseline))
  • Change in Depression Symptoms From Baseline to Post-assessment(1) Baseline (within 2 weeks after enrollment), 2) Post-Assessment (8-12 weeks after baseline))
  • Change in Quality of Life From Baseline to Post-assessment(1) Baseline (within 2 weeks after enrollment), 2) Post-Assessment (8-12 weeks after baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph A. Greer, Ph.D.

Clinical Assistant in Psychology

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验